BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11943951)

  • 21. Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass.
    Fiore CE; Celotta G; Politi GG; Di Pino L; Castelli Z; Mangiafico RA; Signorelli SS; Pennisi P
    Atherosclerosis; 2007 Nov; 195(1):110-5. PubMed ID: 17010978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
    Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
    Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation.
    Voelkl J; Pakladok T; Lin Y; Viereck R; Lebedeva A; Kukuk D; Pichler BJ; Alesutan I; Lang F
    Cell Physiol Biochem; 2014; 33(6):1911-20. PubMed ID: 25011927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective study.
    Triantos CK; Kalafateli M; Samonakis D; Zisimopoulos K; Papiamonis N; Sapountzis A; Michalaki M; Theocharis G; Thomopoulos K; Labropoulou-Karatza C; Kyriazopoulou V; Jelastopulu E; Kouroumalis EA; Nikolopoulou V; Burroughs AK
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1125-32. PubMed ID: 25089543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel hepatokine in rheumatoid arthritis laboratory diagnostics.].
    Papichev EV; Zavodovsky BV; Polyakova YV; Seewordova LE; Akhverdyan YR
    Klin Lab Diagn; 2018; 63(12):756-760. PubMed ID: 30785689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance.
    Goustin AS; Abou-Samra AB
    Cell Signal; 2011 Jun; 23(6):980-90. PubMed ID: 21087662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer.
    Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Kong SY; Tsilidis KK; Weiderpass E; Bueno-De-Mesquita HB; Siersema PD; Jansen EH; Trichopoulou A; Tjønneland A; Olsen A; Wu C; Overvad K; Boutron-Ruault MC; Racine A; Freisling H; Katzke V; Kaaks R; Lagiou P; Trichopoulos D; Severi G; Naccarati A; Mattiello A; Palli D; Grioni S; Tumino R; Peeters PH; Ljuslinder I; Nyström H; Brändstedt J; Sánchez MJ; Gurrea AB; Bonet CB; Chirlaque MD; Dorronsoro M; Quirós JR; Travis RC; Khaw KT; Wareham N; Riboli E; Gunter MJ; Pischon T
    Int J Cancer; 2015 Aug; 137(4):911-20. PubMed ID: 25611809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin as a predictor of survival in cirrhosis.
    Viveiros A; Finkenstedt A; Schaefer B; Mandorfer M; Scheiner B; Lehner K; Tobiasch M; Reiberger T; Tilg H; Edlinger M; Zoller H
    Liver Transpl; 2018 Mar; 24(3):343-351. PubMed ID: 29149510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum fetuin-A is decreased in cirrhotic patients with Wilson's disease.
    Vörös K; Márkus B; Atzél K; Szalay F; Gráf L; Németh D; Masszi T; Torzsa P; Kalabay L
    PLoS One; 2023; 18(3):e0282801. PubMed ID: 36881584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic mapping and functional studies of a natural inhibitor of the insulin receptor tyrosine kinase: the mouse ortholog of human alpha2-HS glycoprotein.
    Cintrón VJ; Ko MS; Chi KD; Gross JP; Srinivas PR; Goustin AS; Grunberger G
    Int J Exp Diabetes Res; 2001; 1(4):249-63. PubMed ID: 11467416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
    Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.
    Heiss A; DuChesne A; Denecke B; Grötzinger J; Yamamoto K; Renné T; Jahnen-Dechent W
    J Biol Chem; 2003 Apr; 278(15):13333-41. PubMed ID: 12556469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.
    Bruns T; Nuraldeen R; Mai M; Stengel S; Zimmermann HW; Yagmur E; Trautwein C; Stallmach A; Strnad P
    Liver Int; 2017 Feb; 37(2):232-241. PubMed ID: 27473364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the gene encoding human alpha 2-HS glycoprotein (AHSG).
    Osawa M; Umetsu K; Sato M; Ohki T; Yukawa N; Suzuki T; Takeichi S
    Gene; 1997 Sep; 196(1-2):121-5. PubMed ID: 9322749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.